|
Aug 8
|
Why Novo Nordisk Stock Flew Higher on Friday
|
|
Aug 8
|
Microsoft, Palantir Get Analyst Attention
|
|
Aug 8
|
Did Eli Lilly Stock Just Have Its Novo Nordisk Moment?
|
|
Aug 8
|
European Equities Traded in the US as American Depositary Receipts Rise Friday
|
|
Aug 8
|
ETFs in Focus on Eli Lilly's Solid Q2 Earnings, Weak Obesity Data
|
|
Aug 8
|
CATL, Novo Nordisk, SoftBank: Global Stocks in Focus
|
|
Aug 8
|
Eli Lilly’s Miracle Weight Loss Pill May Not Be Miraculous Enough
|
|
Aug 8
|
Novo shares rise for second day after Lilly obesity pills trails Wegovy in trial
|
|
Aug 8
|
Heard on the Street Thursday Recap: Apple Keeps the Tariffs Away
|
|
Aug 8
|
Novo Nordisk A/S (NVO) Receives Tender Offer for 2M Shares
|
|
Aug 7
|
Why Eli Lilly (LLY) Shares Are Getting Obliterated Today
|
|
Aug 7
|
Eli Lilly is giving Novo Nordisk a run for its money—so why is LLY stock still down today?
|
|
Aug 7
|
Mounjaro and Zepbound fuel strong Q2 growth for Eli Lilly
|
|
Aug 7
|
European Equities Close Mostly Higher Thursday
|
|
Aug 7
|
Stocks to Watch Thursday: Eli Lilly, Firefly, DoorDash, TSMC
|
|
Aug 7
|
Eli Lilly’s oral GLP-1RA hits endpoints, but trails Novo’s Wegovy in weight loss
|
|
Aug 7
|
LLY Stock Sinks Despite Q2 Earnings Beat as Obesity Pill Disappoints
|
|
Aug 7
|
European Equities Traded in the US as American Depositary Receipts Rise in Thursday Trading
|
|
Aug 7
|
Eli Lilly’s Weight Loss Pill Doesn’t Work as Well as Investors Hoped. The Obesity Trade Is Wavering Again.
|
|
Aug 7
|
Eli Lilly Dives 14% On A Shocking Obesity Setback, Sending Its Rivals Flying
|